Grantham, Mayo, Van Otterloo & Co (GMO)’s Chemours CC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-64,000	Closed	-$3.2M	–	574
2017 Q4	$3.2M	Buy	+64,000	New	+$3.35M	0.02%	281
2016 Q4	–	Sell	-20,900	Closed	-$334K	–	509
2016 Q3	$334K	Sell	20,900 -1,002,644	-98%	-$11.5M	﹤0.01%	423
2016 Q2	$8.43M	Sell	1,023,544 -69,856	-6%	-$622K	0.03%	244
2016 Q1	$7.65M	Buy	1,093,400 +281,100	+35%	+$1.41M	0.03%	262
2015 Q4	$4.35M	Buy	+812,300	New	+$5.19M	0.02%	269

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CC Position: Q1 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Chemours (CC) in Q1 2018, closing a stake of 64,000 shares — an estimated $3.2M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CC in Q4 2015 and held it in 5 quarters. The position peaked at $8.43M in Q2 2016. 547 funds tracked by Wall St. Rank hold CC as of Q1 2018.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Chemours position as of Q1 2018 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 64,000 Chemours shares in Q1 2018, an estimated $3.2M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Chemours in Q4 2015 and held it in 5 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Chemours position peaked at $8.43M in Q2 2016.
547 funds tracked by Wall St. Rank held Chemours as of Q1 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2018, filed 15 May 2018.